Publicaciones (63) Publicaciones de Guillermo Martínez de Tejada de Garaizábal

2024

  1. Dhvar5-chitosan nanogels and their potential to improve antibiotics activity

    International Journal of Biological Macromolecules, Vol. 277

  2. Interspecies transmission of antimicrobial-resistant bacteria between wild birds and mammals in urban environment

    Veterinary Microbiology, Vol. 294

  3. Supramolecular assembly of micellar aggregates is the basis of low endotoxin recovery (LER) in a drug formulation that can be resolved by a whole blood assay

    Biomedicine and Pharmacotherapy, Vol. 173

2023

  1. A Comparison between SARS-CoV-2 and Gram-Negative Bacteria-Induced Hyperinflammation and Sepsis

    International Journal of Molecular Sciences, Vol. 24, Núm. 20

2022

  1. Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial

    Clinical Infectious Diseases, Vol. 75, Núm. 1, pp. E585-E593

  2. Repurposing the Antibacterial Agents Peptide 19-4LF and Peptide 19-2.5 for Treatment of Cutaneous Leishmaniasis

    Pharmaceutics, Vol. 14, Núm. 11

2021

  1. Activity of anti-microbial peptides (Amps) against leishmania and other parasites: An overview

    Biomolecules, Vol. 11, Núm. 7

  2. An antibiotic potentiator retains its activity after being immobilized on silicone and prevents growth of multidrug-resistant Pseudomonas aeruginosa biofilms

    Materials Science and Engineering C, Vol. 121

  3. An update on endotoxin neutralization strategies in Gram-negative bacterial infections

    Expert Review of Anti-Infective Therapy, Vol. 19, Núm. 4, pp. 495-517

  4. Anti-infective and anti-inflammatory mode of action of peptide 19-2.5

    International Journal of Molecular Sciences, Vol. 22, Núm. 3, pp. 1-18

  5. Antimicrobial peptides in the battle against orthopedic implant-related infections: A review

    Pharmaceutics, Vol. 13, Núm. 11

  6. Cathelicidin and PMB neutralize endotoxins by multifactorial mechanisms including LPS interaction and targeting of host cell membranes

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 118, Núm. 27

2020

  1. A synthetic peptide sensitizes multi-drug resistant Pseudomonas aeruginosa to antibiotics for more than two hours and permeabilizes its envelope for twenty hours

    Journal of Biomedical Science, Vol. 27, Núm. 1

  2. Permeability enhancers sensitize β-lactamase-expressing Enterobacteriaceae and Pseudomonas aeruginosa to β-lactamase inhibitors, thereby restoring their β-lactam susceptibility

    International Journal of Antimicrobial Agents, Vol. 56, Núm. 1

2019

  1. A permeability-increasing drug synergizes with bacterial efflux pump inhibitors and restores susceptibility to antibiotics in multi-drug resistant Pseudomonas aeruginosa strains

    Scientific Reports, Vol. 9, Núm. 1

  2. AMPs as anti-biofilm agents for human therapy and prophylaxis

    Advances in Experimental Medicine and Biology (Springer New York LLC), pp. 257-279

  3. Antibacterial action of synthetic antilipopolysaccharide peptides (SALP) involves neutralization of both membrane-bound and free toxins

    FEBS Journal, Vol. 286, Núm. 8, pp. 1576-1593

  4. Development of Antimicrobial Peptides Based on Limulus Anti-Lipopolysaccharide Factor (LALF)

    Endotoxin Detection and Control in Pharma, Limulus, and Mammalian Systems, pp. 683-706

  5. Inactivation of Bacteria by γ-Irradiation to Investigate the Interaction with Antimicrobial Peptides

    Biophysical Journal, Vol. 117, Núm. 10, pp. 1805-1819

  6. LPS-neutralizing peptides reduce outer membrane vesicle-induced inflammatory responses

    Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1864, Núm. 10, pp. 1503-1513